# Dexamethasone Implant for Retinal Detachment in Uveal Melanoma

> **NCT04082962** · PHASE1 · COMPLETED · sponsor: **Ivana K. Kim** · enrollment: 10 (actual)

## Conditions studied

- Exudative Retinal Detachment and Uveal Melanoma

## Interventions

- **DRUG:** Dexamethasone intravitreal implant

## Key facts

- **NCT ID:** NCT04082962
- **Lead sponsor:** Ivana K. Kim
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-11
- **Primary completion:** 2023-12-07
- **Final completion:** 2023-12-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04082962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04082962, "Dexamethasone Implant for Retinal Detachment in Uveal Melanoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04082962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*